Form 4: Equillium CFO Jason Keyes Sells 10,000 Shares Under 10b5-1 Trading Plan

Equillium's Chief Financial Officer, Jason Keyes, sold 10,000 shares of common stock on July 16, 2024, at an average price of $0.87, according to a Form 4 filing with the SEC.

Summary

• Jason Keyes, the Chief Financial Officer of Equillium, Inc., reported a transaction involving the sale of Equillium's common stock on July 16, 2024.
• The sale involved 10,000 shares at a weighted average price of $0.87 per share.
• The transaction was executed under a pre-arranged 10b5-1 trading plan adopted on March 27, 2024.
• Following the transaction, Keyes directly owns 73,913 shares and indirectly owns 67,720 shares through The Keyes Trust Dated September 10, 2004.
• The direct holdings include 15,000 shares acquired through the company's 2018 Employee Stock Purchase Plan on June 10, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a routine stock sale by an executive under a pre-existing trading plan. It doesn't inherently indicate positive or negative sentiment.

Industry Context

Form 4 filings are standard practice and provide transparency into the trading activities of company insiders. The use of a 10b5-1 trading plan suggests that the sales were pre-planned and not based on any specific non-public information.

Stakeholder Impact

• The stock sale by a key executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates